{"id":246,"date":"2020-10-26T14:05:14","date_gmt":"2020-10-26T14:05:14","guid":{"rendered":"https:\/\/www.embl.org\/about\/info\/szilard-library\/?page_id=246"},"modified":"2026-01-14T13:13:38","modified_gmt":"2026-01-14T13:13:38","slug":"deal-agreement","status":"publish","type":"page","link":"https:\/\/www.embl.org\/about\/info\/szilard-library\/open-access\/open-access-agreements-with-publishers\/deal-agreement\/","title":{"rendered":"DEAL Agreement"},"content":{"rendered":"\n
\n
\n\n

Projekt DEAL<\/a>\u00a0<\/strong>enables scientists at all EMBL sites to publish Open Access for free (in hybrid\/open choice journals) or with a 20% discount (in full Open Access journals) and grants access to almost the entire journal portfolio of Wiley and Springer Nature. EMBL has joined the two successfully negotiated DEAL agreements with Wiley and Springer Nature. Projekt DEAL is an initiative of the\u00a0Alliance of German Science Organizations\u00a0to negotiate nationwide transformative \u201cpublish and read\u201d agreements with the largest commercial publishers of scholarly journals on behalf of all German academic institutions, including universities, universities of applied sciences, research institutions, state and regional libraries. Although DEAL is a national project in Germany, EMBL is eligible to participate with all its sites.<\/p>\n\n\n\n

What is the DEAL agreement?<\/strong><\/h2>\n\n\n\n

The DEAL agreements are Read & Publish licensing agreements concluded between the Alliance of German Science Organizations and Wiley and Springer Nature. It offers participating institutions access to the publisher\u2019s full eJournal portfolio (1600 titles in a range of disciplines) while supporting and facilitating Open Access publishing.<\/p>\n\n\n\n

The Wiley agreement and the Springer Nature agreements are valid for the period 2024 \u2013 2028. The DEAL agreements are transformative agreements compliant with Plan S principles.\u00a0<\/p>\n\n\n\n

What does it mean for you?<\/strong><\/h2>\n\n\n\n

 The agreement offers to EMBL\u2019s affiliating authors at all sites a number of benefits:<\/p>\n\n\n\n

Wiley<\/strong><\/p>\n\n\n\n